Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma: a subgroup analysis from the LOTIS-2 study

Juan Pablo Alderuccio, Weiyun Z Ai, John Radford, Melhem M Solh, Kirit M Ardeshna, Matthew Lunning, Brian Hess, Pier Luigi Zinzani, Anastasios Stathis, Carmelo Carlo Stella, Mehdi Hamadani, Brad S Kahl, David Ungar, Turk Kilavuz, Eric Yu, Yajuan Gu Qin, Paolo F Caimi

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)4736-4739
Number of pages4
JournalBlood Advances
Issue number16
Publication statusPublished - 16 Aug 2022

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Cite this